A 12 Week, Open Label, Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular Depression
Phase of Trial: Phase IV
Latest Information Update: 03 Mar 2017
Price : $35 *
At a glance
- Drugs Desvenlafaxine (Primary)
- Indications Depression; Major depressive disorder
- Focus Therapeutic Use
- 18 Mar 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov record.
- 18 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 18 Nov 2013 New trial record